These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 21233240)

  • 1. Ovarian cancer guidelines: treatment progress and controversies.
    Morgan RJ
    J Natl Compr Canc Netw; 2011 Jan; 9(1):4-5. PubMed ID: 21233240
    [No Abstract]   [Full Text] [Related]  

  • 2. Intraperitoneal chemotherapy in ovarian cancer remains experimental.
    Gore M; du Bois A; Vergote I
    J Clin Oncol; 2006 Oct; 24(28):4528-30. PubMed ID: 17008689
    [No Abstract]   [Full Text] [Related]  

  • 3. Ovarian cancer and the battle of the specialists.
    McGuire WP
    J Clin Oncol; 2007 Aug; 25(23):3554-5; author reply 3557-8. PubMed ID: 17687166
    [No Abstract]   [Full Text] [Related]  

  • 4. The organization of clinical trials for oncology at IRCCS Istituto Nazionale Tumori "Fondazione G. Pascale" Napoli and the impact of the OECI accreditation process.
    De Feo G; D'Ambrosio F; Palmieri G; Perrone F; Ciliberto G
    Tumori; 2015; 101 Suppl 1():S33-7. PubMed ID: 27096270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical practice guidelines for the adverse events in medical oncology].
    Isobe T; Hayashi M; Tsubata Y
    Nihon Rinsho; 2015 Feb; 73 Suppl 2():45-50. PubMed ID: 25831722
    [No Abstract]   [Full Text] [Related]  

  • 6. Chemotherapy in epithelial ovarian cancer.
    Pignata S; Cannella L; Leopardo D; Pisano C; Bruni GS; Facchini G
    Cancer Lett; 2011 Apr; 303(2):73-83. PubMed ID: 21353386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of nonrandomized trials in the evaluation of oncology drugs.
    Simon R; Blumenthal GM; Rothenberg ML; Sommer J; Roberts SA; Armstrong DK; LaVange LM; Pazdur R
    Clin Pharmacol Ther; 2015 May; 97(5):502-7. PubMed ID: 25676488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Geriatric oncology aims for clinical trials.
    Sinha G
    J Natl Cancer Inst; 2006 Nov; 98(21):1516-8. PubMed ID: 17077352
    [No Abstract]   [Full Text] [Related]  

  • 9. Measuring the evidence that informs clinical treatment recommendations.
    Vandergrift JL
    J Natl Compr Canc Netw; 2012 May; 10(5):678-80. PubMed ID: 22570296
    [No Abstract]   [Full Text] [Related]  

  • 10. [Foreward].
    Ehninger G; Overkamp F; Freund M;
    Onkologie; 2013; 36 Suppl 2():1. PubMed ID: 23549029
    [No Abstract]   [Full Text] [Related]  

  • 11. Drug therapy: Preclinical oncology - reporting transparency needed.
    Gardner EE; Rudin CM
    Nat Rev Clin Oncol; 2016 Jan; 13(1):8-9. PubMed ID: 26667971
    [No Abstract]   [Full Text] [Related]  

  • 12. Personalizing cancer care: American Society of Clinical Oncology presidential address 2009.
    Schilsky RL
    J Clin Oncol; 2009 Aug; 27(23):3725-30. PubMed ID: 19581526
    [No Abstract]   [Full Text] [Related]  

  • 13. The American Society of Clinical Oncology guideline program.
    Winn RF; Smith TF
    Pharm Pract Manag Q; 1996 Apr; 16(1):31-8. PubMed ID: 10157738
    [No Abstract]   [Full Text] [Related]  

  • 14. [Standards, Options: Recommendations for the management of patients with epithelial ovarian cancer. Medical front-line treatment (summary report, update 2008)].
    Fédération nationale des centres de lutte contre le cancer (FNCLCC)
    Gynecol Obstet Fertil; 2008 Jun; 36(6):684-700. PubMed ID: 18539509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Systemic therapies administration for adult patients in neuro-oncology: The standards of the Association of the neuro-oncologists of French expression (ANOCEF)].
    Simon N; Vasseur M; Chauffert B; Taillandier L; Le Rhun E
    Bull Cancer; 2016 Apr; 103(4):400-1. PubMed ID: 26874975
    [No Abstract]   [Full Text] [Related]  

  • 16. [Association Dermatologic Oncology (ADO). Treatment of advanced squamous cell carcinoma].
    Hillen U; Ulrich C; Gutzmer R; Becker JC
    J Dtsch Dermatol Ges; 2013 Jul; 11(7):699. PubMed ID: 23802798
    [No Abstract]   [Full Text] [Related]  

  • 17. Type of oncology specialist and treatment-related outcomes in ovarian cancer.
    Hoffman MA; Iqbal U
    J Clin Oncol; 2007 Aug; 25(23):3553; author reply 3557-8. PubMed ID: 17687165
    [No Abstract]   [Full Text] [Related]  

  • 18. Advanced cancer of the ovary: intraperitoneal chemotherapy as a new therapeutical option.
    Fiorentini G; Filippeschi M; Turrisi G; Mambrini A; Giannessi PG; D'Alessandro M; Rossi S; Dentico P; Guadagni S; Cantore M; Madrigali A
    In Vivo; 2009; 23(2):317-21. PubMed ID: 19414421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotherapy administration for ovarian cancer by gynecologic oncologists and medical oncologists.
    Berchuck A
    J Clin Oncol; 2007 Aug; 25(23):3552; author reply 3557-8. PubMed ID: 17687164
    [No Abstract]   [Full Text] [Related]  

  • 20. Does ovarian cancer treatment and survival differ by the specialty providing chemotherapy?
    Markman M
    J Clin Oncol; 2007 Aug; 25(23):3554; author reply 3557-8. PubMed ID: 17687167
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.